Philip Murphy, MD, Beaumont Hospital, Dublin, Ireland, gives his highlights from the International Myeloma Society (IMS) Meeting that was held in Los Angeles, CA, in August 2022. These include updates in CAR-T therapy for multiple myeloma and further insights into COVID-19 vaccination in patients with multiple myeloma. Prof. Murphy also highlights what he’s looking forward to hearing more about at ASH 2022, including the use of cellular therapies in multiple myeloma. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.